<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Overview and pathophysiology of renal tubular acidosis and the effect on potassium balance</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Overview and pathophysiology of renal tubular acidosis and the effect on potassium balance</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Overview and pathophysiology of renal tubular acidosis and the effect on potassium balance</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael Emmett, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Ellie Kelepouris, MD, FAHA</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Richard H Sterns, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John P Forman, MD, MSc</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Sep 28, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The lungs and the kidneys are responsible for the maintenance of acid-base balance within the body. Alveolar ventilation removes carbon dioxide, while the kidneys reclaim filtered bicarbonate and excrete hydrogen ions produced by the metabolism of dietary protein (or bicarbonate when the diet generates more base than acid).</p><p>The term "renal tubular acidosis" (RTA) refers to a group of disorders in which, despite a relatively well-preserved glomerular filtration rate, metabolic acidosis develops because of defects in the ability of the renal tubules to perform the normal functions required to maintain acid-base balance [<a href="#rid1">1</a>]. All forms of RTA are characterized by a normal anion gap (hyperchloremic) metabolic acidosis. This form of metabolic acidosis usually results from either the net retention of hydrogen chloride or a salt that is metabolized to hydrogen chloride (such as ammonium chloride) or the net loss of <a class="drug drug_general" data-topicid="9928" href="/z/d/drug information/9928.html" rel="external">sodium bicarbonate</a> or its equivalent [<a href="#rid2">2</a>]. The most common cause of a normal anion gap acidosis in patients without a significant impairment in kidney function is diarrhea. (See  <a class="medical medical_review" href="/z/d/html/2291.html" rel="external">"Approach to the adult with metabolic acidosis"</a>.)</p><p>This topic will review the classification and pathophysiology of the different forms of RTA and the impact these disorders have on potassium balance. The major causes, diagnosis, and treatment of RTA are discussed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/2328.html" rel="external">"Etiology and diagnosis of distal (type 1) and proximal (type 2) renal tubular acidosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/2329.html" rel="external">"Treatment of distal (type 1) and proximal (type 2) renal tubular acidosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/2377.html" rel="external">"Causes and evaluation of hyperkalemia in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/2306.html" rel="external">"Etiology, diagnosis, and treatment of hypoaldosteronism (type 4 RTA)"</a>.)</p><p></p><p class="headingAnchor" id="H2274762871"><span class="h1">ROLE OF THE KIDNEY IN ACID-BASE AND POTASSIUM BALANCE</span><span class="headingEndMark"> — </span>Prior to discussing renal tubular acidosis (RTA), it is helpful to briefly review the kidneys' role in the maintenance of acid-base and potassium balance and how disturbances in tubular function can result in metabolic acidosis and an abnormal serum potassium.</p><p>To maintain acid-base balance in individuals ingesting a typical (acid generating) Western diet, the kidneys reclaim the filtered bicarbonate and excrete the daily acid load, which is primarily derived from the metabolism of sulfur-containing amino acids.</p><p class="headingAnchor" id="H2274762877"><span class="h2">Reclaiming filtered bicarbonate</span><span class="headingEndMark"> — </span>The bicarbonate that is filtered by the glomeruli returns to the circulation, predominately as a result of sodium-hydrogen exchange by the proximal tubules  (<a class="graphic graphic_figure graphicRef60730" href="/z/d/graphic/60730.html" rel="external">figure 1</a>). Approximately 80 to 85 percent of the filtered load is reclaimed at this site. The remaining 15 to 20 percent is reclaimed in the thick ascending limb of Henle and the collecting tubules via sodium-hydrogen exchange and hydrogen secretion by proton pumps (H-ATPase and H-K ATPase). Under normal conditions, when a typical Western diet is ingested, there is virtually no bicarbonate in the final urine.</p><p class="headingAnchor" id="H2274762883"><span class="h2">Acid excretion</span><span class="headingEndMark"> — </span>The excretion of the daily hydrogen ion load is primarily a function of the connecting and collecting tubules. The average daily acid load generated by a typical Western diet is approximately 1 mEq/kg of body weight. Excretion of this acid load in the urine requires urinary buffers to bind hydrogen ions. If hydrogen ions were free and not buffered in the urine, the daily excretion of 50 to 70 mEq of acid in 1 liter of urine would require a urine pH of less than 2.5, which represents a pH gradient between the cell interior and the tubular lumen of 100,000 to 1. Such a gradient cannot be achieved by the tubular cell. The minimum urine pH in humans is 4.5 to 5.</p><p>The principal conjugate buffering pairs in the urine are ammonia-ammonium (NH<sub>3</sub> and NH<sub>4</sub><sup>+</sup>) and phosphate (HPO<sub>4</sub><sup>-2</sup> and H<sub>2</sub>PO<sub>4</sub><sup>-1</sup>); phosphate is the major component of "titratable acid." Ammonium excretion requires the renal synthesis of ammonia, which diffuses and is secreted into the lumen, and the secretion of hydrogen ions into the tubular lumen, where they are "trapped" as ammonium (NH<sub>3</sub> + H<sup>+</sup> → NH<sub>4</sub><sup>+</sup>). Uncharged ammonia can diffuse freely across membranes, while the positively charged ammonium ion is relatively impermeant [<a href="#rid3">3</a>].</p><p>The renal tubular production of ammonia is stimulated by intracellular acidosis. When the systemic acid load is modestly increased, near-normal balance is maintained by increases in ammonium production and excretion  (<a class="graphic graphic_figure graphicRef80366" href="/z/d/graphic/80366.html" rel="external">figure 2</a>). Failure to excrete sufficient ammonium often leads to the net retention of hydrogen ions and the development of metabolic acidosis.</p><p class="headingAnchor" id="H2274762636"><span class="h1">POTASSIUM METABOLISM BY THE KIDNEY</span><span class="headingEndMark"> — </span>Almost all of the filtered potassium is reabsorbed passively in the proximal tubule and loop of Henle. Most potassium excreted in the urine is derived from potassium secretion into the tubular lumen by cells in the distal nephron, particularly the connecting tubule and the principal cells in the cortical collecting tubule [<a href="#rid4">4</a>].</p><p>Distal potassium secretion is primarily influenced by two factors, both of which promote sodium reabsorption: aldosterone and the distal delivery of sodium and water  (<a class="graphic graphic_figure graphicRef60693" href="/z/d/graphic/60693.html" rel="external">figure 3</a>) [<a href="#rid5">5-7</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Aldosterone acts, in part, by increasing the number of open sodium channels in the luminal membrane of the distal tubule. Because the luminal sodium concentration is usually much higher than the intracellular sodium concentration, an increased density of open sodium channels results in increased sodium reabsorption from the tubular lumen into the tubular cell; absorbed sodium is then transported out of the cell into the peritubular capillaries in exchange for potassium by sodium-potassium ATPase located on the cell's basolateral membrane.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Distal tubule reabsorption of sodium is more rapid than chloride reabsorption, which results in a relatively electronegative lumen. This relative negative charge provides a favorable gradient for secretion of positively charged ions (potassium and hydrogen ions) from the tubular cell into the lumen through potassium channels in the luminal membrane.</p><p></p><p>Although these mechanisms are of major importance in potassium balance, a number of other molecular regulatory mechanisms that contribute to potassium homeostasis have been subsequently described [<a href="#rid8">8</a>]. </p><p>Alterations in potassium excretion are common in patients with renal tubular acidosis (RTA) and, depending upon the site of the defect and the mechanism responsible for the various forms of RTA, can result in hypokalemia or hyperkalemia. As will be discussed, hyperkalemia can also contribute to the development of metabolic acidosis.</p><p>All forms of RTA produce hyperchloremic (normal anion gap) metabolic acidosis. Some forms of RTA cause potassium wasting and hypokalemia; other forms are associated with positive potassium balance and hyperkalemia. The treatment of RTA also has variable effects on potassium balance and serum potassium.</p><p class="headingAnchor" id="H3888425765"><span class="h1">CLASSIFICATION OF RTA</span><span class="headingEndMark"> — </span>There are four major forms of renal tubular acidosis (RTA). Two are hypokalemic, and two are hyperkalemic. The two hypokalemic RTAs are classic distal (type 1) and proximal (type 2). The hyperkalemic RTAs are hypoaldosteronism (type 4) and voltage-dependent RTA, which some consider a subtype of distal RTA. These major forms of RTA differ in their pathophysiology and clinical manifestations  (<a class="graphic graphic_table graphicRef58428" href="/z/d/graphic/58428.html" rel="external">table 1</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Distal (type 1) RTA is caused by defects in distal hydrogen ion excretion  (<a class="graphic graphic_table graphicRef56437" href="/z/d/graphic/56437.html" rel="external">table 2</a>). (See <a class="local">'Distal (type 1) RTA'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Proximal (type 2) RTA is caused by defects that reduce the capacity to reclaim filtered bicarbonate in the proximal tubule  (<a class="graphic graphic_table graphicRef68165" href="/z/d/graphic/68165.html" rel="external">table 3</a>). (See <a class="local">'Proximal (type 2) RTA'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hypoaldosteronism (type 4 RTA) is caused by reductions in aldosterone secretion or responsiveness  (<a class="graphic graphic_table graphicRef82440" href="/z/d/graphic/82440.html" rel="external">table 4</a>). (See <a class="local">'Hypoaldosteronism'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Voltage-dependent RTA is caused by defects in distal sodium reabsorption, which affect the negative electric potential difference normally generated in the distal tubule. (See <a class="local">'Voltage-dependent RTA'</a> below.)</p><p></p><p class="headingAnchor" id="H5"><span class="h1">DISTAL (TYPE 1) RTA</span><span class="headingEndMark"> — </span>Distal (type 1) renal tubular acidosis (RTA) is characterized by impaired hydrogen ion secretion in the distal nephron, which reduces the kidney's ability to excrete the daily acid load (50 to 100 mEq on a typical Western diet). This results in progressive hydrogen ion retention and a normal anion gap (or hyperchloremic) metabolic acidosis. If untreated, the plasma bicarbonate concentration can fall below 10 mEq/L. Patients with distal RTA almost always have hypocitraturia and frequently develop kidney calcifications and calcium-containing (frequently calcium phosphate) kidney stones. (See  <a class="medical medical_review" href="/z/d/html/2328.html" rel="external">"Etiology and diagnosis of distal (type 1) and proximal (type 2) renal tubular acidosis"</a> and  <a class="medical medical_review" href="/z/d/html/7375.html" rel="external">"Kidney stones in adults: Epidemiology and risk factors", section on 'Low urine citrate'</a>.)</p><p>Distal RTA is commonly associated with hypokalemia due to renal potassium wasting [<a href="#rid9">9,10</a>]. Occasionally, the hypokalemia is so severe (ie, serum potassium below 2 mEq/L) that it results in muscle paralysis or respiratory arrest [<a href="#rid11">11</a>].</p><p>The secretion of hydrogen ions into the lumen of the distal tubule is mainly accomplished by type A (alpha) intercalated cells in the connecting and collecting tubules via a luminal H-ATPase pump and, to a lesser degree, via an H-K-ATPase pump that secretes hydrogen ions and reabsorbs potassium  (<a class="graphic graphic_figure graphicRef51361" href="/z/d/graphic/51361.html" rel="external">figure 4</a>). By contrast, the site of distal tubule potassium secretion is primarily the principal cells in the connecting and collecting tubules  (<a class="graphic graphic_figure graphicRef60693" href="/z/d/graphic/60693.html" rel="external">figure 3</a>) [<a href="#rid12">12,13</a>].</p><p>The general underlying pathophysiology of distal RTA is either:</p><p class="bulletIndent1"><span class="glyph">●</span>Decreased net activity of the proton pumps – the most common mechanism (see <a class="local">'Decreased net activity of proton pumps and HCO3 exchangers'</a> below)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Increased hydrogen ion permeability of the luminal membrane – which is much less common (see <a class="local">'Increased luminal membrane permeability'</a> below)</p><p></p><p class="headingAnchor" id="H6"><span class="h2">Decreased net activity of proton pumps and HCO3 exchangers</span><span class="headingEndMark"> — </span>Diminished H-ATPase activity  (<a class="graphic graphic_figure graphicRef51361" href="/z/d/graphic/51361.html" rel="external">figure 4</a>) can be due to a variety of mutations in genes encoding different subunits of this pump; most follow an autosomal recessive inheritance pattern [<a href="#rid14">14</a>]. In addition, both autosomal dominant and recessive mutations of the <em>SLC4A1</em>/anion exchanger 1, which exchanges serum bicarbonate (HCO<sub>3</sub>) for chloride on the basolateral side of the alpha intercalated cells, have been described [<a href="#rid14">14</a>]. These defects impair the ability to maximally acidify the urine, and in most patients with distal RTA, the urine pH cannot be reduced below 5.5 despite systemic acidemia (individuals without this disorder can reduce the urine pH to 5 or lower).</p><p>However, occasional patients with genetic forms of distal RTA can reduce their urine pH slightly below 5.5. As an example, 2 of 17 patients with distal RTA due to decreased expression of the proton pump were able to reduce their urine pH to 5.24 and 5.38 [<a href="#rid15">15</a>]. In such patients, distal RTA should still be suspected if other causes of a hyperchloremic or normal anion gap metabolic acidosis have been excluded  (<a class="graphic graphic_table graphicRef77464" href="/z/d/graphic/77464.html" rel="external">table 5</a>). Specialized diagnostic techniques, such as measurement of the urine-to-blood partial pressure of carbon dioxide gradient, can establish a diagnosis of distal RTA in such patients [<a href="#rid15">15,16</a>]. Genetic testing for these mutations is also available. (See  <a class="medical medical_review" href="/z/d/html/2328.html" rel="external">"Etiology and diagnosis of distal (type 1) and proximal (type 2) renal tubular acidosis", section on 'Urine pH'</a>.)</p><p>When distal RTA is suspected and other, more common causes of normal anion gap metabolic acidosis are not present, the simplest diagnostic approach is to measure the urine pH several times to see whether values below 5.5 can be documented. If the urine pH is persistently 5.5 or higher, despite systemic acidemia, a renal acidification defect may exist (although other causes of an inappropriately high urine pH, such as urinary tract infection, should be considered). If the urine pH is between 5.2 and 5.5, a subtle acidification defect may still be present.</p><p>It is important to note that the urine pH must be measured with a pH electrode; pH measurements using color indicators or dipsticks are <strong>not</strong> adequate.</p><p>A number of different genetic and acquired defects can directly or indirectly decrease the net activity of the distal tubule proton pump [<a href="#rid17">17</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sjögren's disease</strong> – Immunocytochemical analyses of kidney biopsies obtained from some patients with Sjögren's disease have shown complete absence of H-ATPase pumps in the intercalated cells  (<a class="graphic graphic_figure graphicRef51361" href="/z/d/graphic/51361.html" rel="external">figure 4</a>) [<a href="#rid18">18,19</a>]. How immunologic injury leads to this change is not known.</p><p></p><p class="bulletIndent1">High titers of an autoantibody directed against carbonic anhydrase II have also been identified in some patients with Sjögren's disease [<a href="#rid20">20</a>]. Inhibition of carbonic anhydrase II probably impairs intracellular generation of hydrogen ions, which would diminish the capacity for hydrogen ion secretion by the proton pump  (<a class="graphic graphic_figure graphicRef51361" href="/z/d/graphic/51361.html" rel="external">figure 4</a>). (See  <a class="medical medical_review" href="/z/d/html/7187.html" rel="external">"Kidney disease in primary Sjögren's disease"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>kAE1 (</strong><strong><em>SLC4A1</em></strong><strong>/anion exchanger 1)</strong> <strong>mutations</strong> – The kidney chloride-bicarbonate exchanger (kAE1), located on the basolateral cell membrane in the distal tubule, is necessary to efficiently transport intracellular bicarbonate, generated by the luminal secretion of hydrogen ions, into the peritubular blood in exchange for chloride  (<a class="graphic graphic_figure graphicRef51361" href="/z/d/graphic/51361.html" rel="external">figure 4</a>). Mutations in the gene (<em>SLC4A1</em>) that codes for this exchanger have been identified in some families with autosomal dominant (more common) and autosomal recessive (less common) forms of distal RTA [<a href="#rid21">21-31</a>].</p><p></p><p class="bulletIndent1">The mutations of the chloride-bicarbonate exchanger gene can generate distal RTA through at least two distinct pathophysiologic mechanisms that impair hydrogen ion secretion:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A malfunction of kAE1, which prevents bicarbonate exit from the cell. The resulting rise in cell pH impedes hydrogen ion generation and secretion.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Aberrant trafficking of an otherwise normal basolateral kAE1 to the luminal, rather than basolateral, membrane. This results in bicarbonate secretion into the lumen, which neutralizes the hydrogen ions secreted into the lumen [<a href="#rid31">31-34</a>].</p><p></p><p class="bulletIndent1">A different splice form of the chloride-bicarbonate exchanger (eAE1 or band 3 protein) is present in the red cell membrane, and some mutations of this exchanger cause hereditary spherocytosis and Southeast Asian ovalocytosis. Sometimes, mutations result in both the hematologic disorders and distal RTA [<a href="#rid35">35-37</a>]. (See  <a class="medical medical_review" href="/z/d/html/7079.html" rel="external">"Hereditary spherocytosis"</a> and  <a class="medical medical_review" href="/z/d/html/142822.html" rel="external">"Southeast Asian ovalocytosis (SAO)", section on 'Specific SLC4A1 deletion'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>H-ATPase mutations</strong> – Mutations in the genes that encode either the B1 or A4 subunits of the H-ATPase pump (<em>ATP6V1B1</em> and <em>ATP6V0A4</em>) can impair the function of the proton pump [<a href="#rid26">26</a>]. Defects in either subunit may also be associated with sensorineural deafness, suggesting that the proton pump is required for normal function of the inner ear [<a href="#rid14">14,38,39</a>].</p><p></p><p>Untreated patients with a <strong>proton pump defect</strong> tend to waste potassium and become hypokalemic [<a href="#rid10">10,40</a>]. The potassium wasting is linked to the reduction in distal hydrogen ion secretion via several mechanisms:</p><p class="bulletIndent1"><span class="glyph">●</span>Sodium that is reabsorbed in the collecting tubules must, in order to maintain electroneutrality, be reabsorbed with an anion, such as chloride or bicarbonate, or in exchange for a cation, such as potassium  (<a class="graphic graphic_figure graphicRef60693" href="/z/d/graphic/60693.html" rel="external">figure 3</a>) or hydrogen  (<a class="graphic graphic_figure graphicRef51361" href="/z/d/graphic/51361.html" rel="external">figure 4</a>). If hydrogen ion secretion is impaired, potassium secretion generally increases.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Defective intercalated cell H-ATPase generates some sodium wasting [<a href="#rid40">40</a>], and this stimulates the renin-angiotensin-aldosterone system.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Metabolic acidosis inhibits a component of proximal tubule sodium reabsorption [<a href="#rid41">41</a>]. Diminished proximal reabsorption delivers more sodium to the distal tubule sites where aldosterone acts; sodium reabsorption by the distal nephron is generally associated with potassium secretion.</p><p></p><p>Potassium wasting generated by these mechanisms can be largely <strong>reversed</strong> by adequate oral alkali therapy (eg, <a class="drug drug_general" data-topicid="9928" href="/z/d/drug information/9928.html" rel="external">sodium bicarbonate</a> or sodium citrate), which reduces potassium secretion by one or both of the following changes:</p><p class="bulletIndent1"><span class="glyph">●</span>Increased <a class="drug drug_general" data-topicid="9928" href="/z/d/drug information/9928.html" rel="external">sodium bicarbonate</a> delivery to the distal nephron raises the tubule fluid pH and allows more hydrogen (instead of potassium) to be secreted before a limiting pH gradient is reached.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The administered sodium load expands the extracellular fluid volume. This reduces the drive for sodium reabsorption and also reduces aldosterone secretion. As a result, collecting tubule sodium reabsorption and potassium secretion both fall.</p><p></p><p class="bulletIndent1">Thus, hypokalemia generally resolves with adequate treatment of the acidemia in patients with distal RTA.</p><p></p><p>The acid-secreting type A intercalated cells in the cortical and outer medullary collecting tubules have two different proton-secreting pumps in their luminal membranes: an H-ATPase pump that electrogenically secretes hydrogen ions and an electrically neutral H-K-ATPase pump that secretes hydrogen ions and reabsorbs potassium ions  (<a class="graphic graphic_figure graphicRef51361" href="/z/d/graphic/51361.html" rel="external">figure 4</a>) [<a href="#rid42">42,43</a>]. In most patients with hypokalemia and potassium depletion, the activity of the H-K-ATPase pump is appropriately increased. However, inhibition of, or a defect in, this exchange pump would reduce hydrogen ion secretion and increase net potassium excretion by decreasing potassium reabsorption [<a href="#rid43">43,44</a>].</p><p class="headingAnchor" id="H7"><span class="h2">Increased luminal membrane permeability</span><span class="headingEndMark"> — </span>The ability to generate and maintain a highly acidic urine requires the luminal membrane of the distal nephron to be relatively impermeable to hydrogen ions and carbonic acid. As an example, when the urine pH is 5, the urine hydrogen ion concentration is 250 times the hydrogen ion concentration in the extracellular fluid (pH of 7.4). Increased luminal membrane permeability results in back-leak of secreted hydrogen ions from the urine into the extracellular fluid. This reduces urine acid excretion. Increased luminal membrane permeability to hydrogen ions may also be associated with increased apical cell membrane permeability for potassium and magnesium; these ions then leak from the cell cytoplasm into the urine, causing renal potassium and magnesium wasting.</p><p>Amphotericin B therapy is the most common cause of distal RTA generated by this mechanism. This drug's antifungal action is linked to the creation of pores in the fungal cell membrane. To a lesser degree, amphotericin B creates similar pores in the luminal membrane of distal nephron tubule cells. The resulting increase in membrane permeability allows secreted hydrogen ions to diffuse from the urine back into the tubule cells and then into the extracellular fluid. In addition, the pores allow potassium and magnesium to leak from the tubule cells into the urine. The clinical presentation is a normal anion gap metabolic acidosis that is usually accompanied by hypokalemia and, less frequently, hypomagnesemia [<a href="#rid45">45-47</a>]. (See  <a class="medical medical_review" href="/z/d/html/2364.html" rel="external">"Amphotericin B nephrotoxicity", section on 'Electrolyte and acid-base disorders'</a>.)</p><p>Treatment is similar to the other forms of RTA due to proton pump defects. Alkali therapy allows more hydrogen to be secreted before reaching the limiting pH gradient. Although this may decrease potassium losses, it would not be expected to reduce the component of potassium (and magnesium) wasting related to increased membrane permeability to these ions.</p><p class="headingAnchor" id="H9"><span class="h2">Incomplete distal RTA</span><span class="headingEndMark"> — </span>Patients with incomplete distal renal tubular acidosis (RTA) cannot normally acidify their urine, resulting in a urine pH that is persistently 5.5 or higher, as in the complete forms of distal RTA. However, despite this abnormality, normal net acid excretion is maintained, and the plasma bicarbonate concentration remains in the normal range [<a href="#rid5">5,48</a>]. Maintenance of a normal rate of acid excretion is achieved by an increase in ammonium excretion, which offsets the reduction in titratable acid excretion related to the high urine pH. The increased ammonium excretion in this disorder is in contradistinction to the very low urine ammonium excretion in the other forms of distal RTA.</p><p>An important clinical feature of incomplete distal RTA (similar to classic type I RTA) is persistent hypocitraturia, which contributes to urinary and kidney calcification. (See  <a class="medical medical_review" href="/z/d/html/7375.html" rel="external">"Kidney stones in adults: Epidemiology and risk factors", section on 'Low urine citrate'</a>.)</p><p>The pathogenesis of incomplete distal RTA is not well understood, but in one large family with autosomal recessive distal RTA due to a V-ATPase B1 subunit truncation mutation, some heterozygous carriers manifested incomplete distal RTA [<a href="#rid49">49</a>]. In general, all patients with incomplete distal RTA have a low rate of citrate excretion and a relatively high rate of ammonium excretion, which correlate with a reduction in <strong>proximal tubule</strong> intracellular pH [<a href="#rid50">50</a>]. The proximal tubule cell generates ammonia and reabsorbs most of the filtered citrate [<a href="#rid51">51</a>].</p><p>The development of an abnormally low pH within proximal tubule cells could generate the following sequence [<a href="#rid50">50</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Proximal tubule ammonium and hydrogen ion secretion into the lumen is increased. This is similar to the normal proximal tubule response to metabolic acidosis, which is mediated, at least in part, by a low intracellular pH.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Normal plasma citrate concentration is in the 0.1 to 0.5 mm range, and it is &gt;95 percent completely ionized (ie, in the trivalent [-3]) form. Plasma citrate is freely filtered and largely reabsorbed by the proximal tubule. Normally, between 10 to 30 percent of the filtered load is excreted in the urine. Trivalent citrate is poorly reabsorbed, while the divalent form of citrate (-2) is more efficiently reabsorbed via a sodium-citrate cotransporter. The concentration of citrate (-2) in the tubule lumen increases markedly when the tubule fluid pH falls. The pH of the proximal tubular lumen fluid falls with all forms of metabolic acidosis, including RTA. This increases intraluminal divalent citrate (-2), accelerates citrate reabsorption, and reduces citrate excretion [<a href="#rid51">51</a>]. The reduction in intracellular pH of the proximal tubule cells also accelerates citrate metabolism, reducing the intracellular citrate concentration, further enhancing citrate entry from the tubular lumen into the cell [<a href="#rid51">51</a>]. Low urine citrate concentration increases the risk of kidney calcification and calcium-containing kidney stones.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Much of the ammonium (NH<sub>4</sub><sup>+</sup>) that is secreted in the proximal tubule is reabsorbed in the loop of Henle. The ammonia (NH<sub>3</sub>) is then recycled within the medulla and secreted into the medullary collecting tubule where it combines with hydrogen ions (H<sup>+</sup>) and drives the following reaction to the <strong>right</strong>, raising the urine pH:</p><p></p><div class="formulaContainer"><div class="formula"><p>  NH<sub>3</sub> + H<sup>+</sup>  ↔  NH<sub>4</sub><sup>+</sup></p></div></div><p>Two pathogenic mechanisms have been proposed to explain the reduction in proximal tubule intracellular pH in incomplete distal RTA:</p><p class="bulletIndent1"><span class="glyph">●</span>A subtle distal acidification defect reduces the plasma bicarbonate concentration into the low-normal range, resulting in intermittent, short-lived episodes of overt metabolic acidosis [<a href="#rid52">52,53</a>]. This causes intracellular acidosis within the proximal tubule cells that leads to increased ammonia synthesis and excretion as well as reduced urinary citrate excretion. Early in the course, the increase in ammonium excretion can almost entirely compensate for the distal acidification defect, resulting in maintenance of a near-normal or normal serum bicarbonate concentration.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A pathologic process generates intracellular acidosis in the proximal tubule cells [<a href="#rid50">50</a>]. This will initiate a sequence similar to that described above. Ammonia synthesis increases and urinary citrate excretion falls. If this hypothesis is correct, then incomplete RTA is not initially a distal form of RTA.</p><p></p><p>Over a period of time, some patients with incomplete distal RTA progress to the complete form of distal RTA. Both the toxic effect of high interstitial ammonia concentrations and calcium phosphate precipitation (due to both the high urine pH and the low urine citrate concentration) may contribute to the distal nephron injury. (See  <a class="medical medical_review" href="/z/d/html/7375.html" rel="external">"Kidney stones in adults: Epidemiology and risk factors", section on 'Low urine citrate'</a>.)</p><p class="headingAnchor" id="H42786907"><span class="h1">PROXIMAL (TYPE 2) RTA</span><span class="headingEndMark"> — </span>Proximal (type 2) renal tubular acidosis (RTA) is characterized by a decrease in proximal bicarbonate reabsorptive capacity, resulting initially in bicarbonate wasting and a fall in the serum bicarbonate concentration. A number of discrete transporters, pumps, and enzymes are required for the proximal tubule to reclaim most of the filtered bicarbonate  (<a class="graphic graphic_figure graphicRef60730" href="/z/d/graphic/60730.html" rel="external">figure 1</a>).</p><p>More than 4000 mEq of filtered bicarbonate are reclaimed daily, primarily by the proximal tubule transport processes described below  (<a class="graphic graphic_figure graphicRef60730" href="/z/d/graphic/60730.html" rel="external">figure 1</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Hydrogen ions and bicarbonate are generated from carbonic acid within the proximal tubule cells. The reaction is accelerated by the kidney intracellular isoform of carbonic anhydrase (carbonic anhydrase II). The hydrogen ions are then secreted into the proximal tubule lumen, mainly (80 percent) via the sodium-hydrogen ion exchanger (NHE3) in the luminal membrane and, to a smaller extent (20 percent), by an electrogenic V-type H<sup>+</sup>ATPase. The movement of sodium down the large electrochemical concentration gradient from the lumen (where its concentration is similar to plasma) into the cell (where its concentration is much lower and the electrical charge is negative) drives hydrogen ions in the opposite direction (from the cytoplasm into the lumen). The Na-K-ATPase pump in the basolateral membrane of proximal tubule cells indirectly "drives" this exchange by maintaining the low intracellular sodium concentration.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hydrogen ions that enter the proximal tubule lumen react with filtered bicarbonate to generate carbonic acid, which is rapidly dehydrated to water and carbon dioxide. This dehydration reaction is catalyzed by the membrane-bound luminal enzyme, carbonic anhydrase IV. The carbon dioxide formed in the lumen rapidly enters proximal tubule cells via the aquaporin 1 channel in the luminal membrane.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Within proximal tubule cells, the carbon dioxide is hydrated with water to form carbonic acid. The carbonic acid dissociates into hydrogen and bicarbonate ions. For every hydrogen ion secreted from the cell into the lumen, an intracellular bicarbonate exits the cell across the peritubular membrane. The bicarbonate exit step occurs via a sodium-bicarbonate cotransporter. The net effect of this process is that, for every hydrogen ion molecule secreted into the lumen, a bicarbonate molecule enters the peritubular capillary. Because each hydrogen ion that enters the lumen combines with one bicarbonate ion to form carbonic acid, the net effect of this process is the disappearance of one bicarbonate ion and one sodium ion from the lumen and the appearance of one bicarbonate ion and one sodium ion in the peritubular capillary. This process of <a class="drug drug_general" data-topicid="9928" href="/z/d/drug information/9928.html" rel="external">sodium bicarbonate</a> reclamation is equivalent to sodium bicarbonate reabsorption.</p><p></p><p>Abnormalities of one or more of the multiple proximal tubule transporters, pumps, or enzymes can impair <a class="drug drug_general" data-topicid="9928" href="/z/d/drug information/9928.html" rel="external">sodium bicarbonate</a> reabsorption and cause the bicarbonate wasting found in proximal RTA  (<a class="graphic graphic_figure graphicRef60730" href="/z/d/graphic/60730.html" rel="external">figure 1</a>).</p><p>Several <strong>genetic</strong> forms of proximal RTA have been well defined:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>NHE3 mutations</strong> – Autosomal dominant mutations of the gene that encodes for the luminal membrane sodium-hydrogen exchanger (NHE3) [<a href="#rid54">54</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>NBCe1 mutations</strong> – Mutations (usually autosomal recessive) in the gene coding for the sodium-bicarbonate cotransporter (NBCe1). This mutation is also often associated with ocular abnormalities and short stature [<a href="#rid54">54,55</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Carbonic anhydrase II mutations</strong> – Mutations (usually autosomal recessive) in the gene coding for carbonic anhydrase II. This enzyme is important for both proximal and distal tubule proton generation and secretion. Consequently, these patients usually have both proximal and distal acidification defects. Carbonic anhydrase II is also involved in skeletal metabolism and systemic calcium balance. Consequently, this form of RTA may be associated with osteopetrosis, cerebral calcification, and often, intellectual disability [<a href="#rid56">56-58</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Genetic Fanconi syndrome</strong> – Some forms of proximal RTA are accompanied by defective reabsorption of other ions and molecules that are also normally reabsorbed by the proximal tubule. These include phosphate, uric acid, glucose, and low-molecular-weight proteins such as beta-2 microglobulin. Generalized proximal tubule dysfunction is called Fanconi syndrome. A number of inherited enzymatic disorders are associated with Fanconi syndrome in infants. They include cystinosis, tyrosinemia, and glycogen storage disease  (<a class="graphic graphic_table graphicRef68165" href="/z/d/graphic/68165.html" rel="external">table 3</a>) [<a href="#rid59">59</a>].</p><p></p><p>When<strong> acquired</strong>, proximal RTA is usually associated with generalized proximal tubular dysfunction (ie, Fanconi syndrome) (see  <a class="medical medical_review" href="/z/d/html/2328.html" rel="external">"Etiology and diagnosis of distal (type 1) and proximal (type 2) renal tubular acidosis", section on 'Proximal (type 2) RTA'</a>):</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Drug nephrotoxicity</strong> – Acquired proximal RTA with Fanconi syndrome is often a toxic side effect of a drug, such as <a class="drug drug_general" data-topicid="8552" href="/z/d/drug information/8552.html" rel="external">ifosfamide</a>, <a class="drug drug_general" data-topicid="10035" href="/z/d/drug information/10035.html" rel="external">valproic acid</a>, tenofovir, and other reverse transcriptase inhibitors including drugs in both nucleoside and nucleotide classes [<a href="#rid60">60</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Monoclonal gammopathy</strong> – Another important cause of acquired proximal RTA with Fanconi syndrome in adults is a monoclonal gammopathy [<a href="#rid61">61</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Carbonic anhydrase inhibitors</strong> – Isolated proximal RTA (ie, without Fanconi syndrome) may be caused by medications that inhibit carbonic anhydrase. However, as noted above, this enzyme is also required for normal distal tubule acidification, so the defect generally affects the distal tubule as well  (<a class="graphic graphic_figure graphicRef51361" href="/z/d/graphic/51361.html" rel="external">figure 4</a>). Drugs inhibiting carbonic anhydrase include <a class="drug drug_general" data-topicid="9268" href="/z/d/drug information/9268.html" rel="external">acetazolamide</a>, <a class="drug drug_general" data-topicid="9625" href="/z/d/drug information/9625.html" rel="external">methazolamide</a>, <a class="drug drug_general" data-topicid="9386" href="/z/d/drug information/9386.html" rel="external">dorzolamide</a>, and <a class="drug drug_general" data-topicid="10006" href="/z/d/drug information/10006.html" rel="external">topiramate</a>.</p><p></p><p>Regardless of the specific etiology or mechanism, the degree of acidosis is usually <strong>self-limited</strong> in proximal RTA, and the serum bicarbonate concentration usually stabilizes between 14 and 20 mEq/L. The severity of the acidosis depends upon the severity of the proximal defect and the ability of the distal nephron to reabsorb the increased bicarbonate load delivered by the proximal tubule [<a href="#rid62">62</a>]. As the serum bicarbonate concentration falls, less bicarbonate is filtered, less escapes into the distal nephron, and less is excreted into the urine. Eventually, the serum bicarbonate concentration, and the filtered load, falls to levels that can be "normally" reclaimed by the affected proximal tubule. At this point, a "normal" bicarbonate load is delivered to the distal nephron, which is functioning normally. When the plasma bicarbonate concentration stabilizes at a reduced level (usually between 14 and 20 mEq/L), the collecting tubules function normally, the urine pH can be reduced to 5.3 or less, and daily dietary acid load can be excreted in the form of ammonium and titratable acid.</p><p>The ability of distal tubular bicarbonate reabsorption to compensate for the proximal tubule disorder was illustrated in a child with <strong>no</strong> demonstrable proximal tubular function in whom the serum bicarbonate concentration did not fall below 11 to 12 mEq/L [<a href="#rid63">63</a>].</p><p>Hypokalemia often develops in patients with proximal RTA. However, in contrast to the hypokalemia of distal RTA, which is improved by alkali therapy, hypokalemia in proximal RTA is typically generated or exacerbated by alkali therapy. Thiazide diuretics, which are sometimes used in patients with proximal RTA to generate mild volume contraction and thereby increase proximal bicarbonate reabsorption, may also generate or exacerbate hypokalemia.</p><p>As noted above, in the absence of alkali therapy, the plasma bicarbonate concentration will fall to a level that results in a filtered bicarbonate load that permits all of the filtered bicarbonate to be reabsorbed in the proximal, connecting, and collecting tubules. Once this occurs, the plasma bicarbonate concentration stabilizes at a reduced level (usually between 14 and 20 mEq/L), the collecting tubules then function normally, the urine pH can be reduced to 5.3 or less, and daily dietary acid load can be excreted in the form of ammonium and titratable acid.</p><p>Under these conditions, there may be a modest degree of urinary potassium wasting [<a href="#rid10">10</a>] since all forms of metabolic acidosis diminish proximal sodium reabsorption [<a href="#rid64">64</a>]. The ensuing sodium losses may be sufficient to cause subtle hypovolemia and secondary hyperaldosteronism. The combination of high levels of aldosterone and increased distal sodium delivery will promote sodium reabsorption and potassium secretion in the cortical collecting tubule  (<a class="graphic graphic_figure graphicRef60693" href="/z/d/graphic/60693.html" rel="external">figure 3</a>). However, this is a generally modest effect, and the plasma potassium concentration is usually relatively normal in patients with untreated proximal RTA.</p><p>However, this situation changes when alkali is administered (eg, as <a class="drug drug_general" data-topicid="9928" href="/z/d/drug information/9928.html" rel="external">sodium bicarbonate</a> or sodium citrate). This raises the plasma bicarbonate concentration, increasing the filtered bicarbonate load to a level that exceeds the bicarbonate reabsorptive capacity of the proximal tubule. The increased distal tubule delivery of sodium, bicarbonate, and water combines with hyperaldosteronism generated by the modest hypovolemia and markedly stimulates potassium secretion in the cortical collecting tubule  (<a class="graphic graphic_figure graphicRef60693" href="/z/d/graphic/60693.html" rel="external">figure 3</a>) [<a href="#rid10">10,65</a>]. Thus, most patients with proximal RTA who are treated with alkali will develop hypokalemia and require potassium supplements.</p><p>Thiazide diuretics are frequently used to treat patients with proximal RTA because they contract extracellular fluid volume, which increases proximal tubule sodium and bicarbonate reabsorption. However, thiazide diuretics will also accelerate renal potassium secretion and losses. (See  <a class="medical medical_review" href="/z/d/html/2329.html" rel="external">"Treatment of distal (type 1) and proximal (type 2) renal tubular acidosis", section on 'Proximal (type 2) renal tubular acidosis'</a>.)</p><p class="headingAnchor" id="H348265914"><span class="h1">HYPERKALEMIC FORMS OF RTA</span><span class="headingEndMark"> — </span>Normally, sodium reabsorption by the principal cells of the connecting segment and cortical collecting tubule  (<a class="graphic graphic_figure graphicRef60693" href="/z/d/graphic/60693.html" rel="external">figure 3</a>) has a major impact on both potassium and hydrogen ion secretion at these sites  (<a class="graphic graphic_figure graphicRef51361" href="/z/d/graphic/51361.html" rel="external">figure 4</a>). These effects occur via the following mechanisms:</p><p class="bulletIndent1"><span class="glyph">●</span>Sodium reabsorption by the principal cells is more rapid than chloride reabsorption. This creates a negative electrical field within the lumen.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The luminal electronegativity promotes secretion of positively charged potassium ions from the principal cells  (<a class="graphic graphic_figure graphicRef60693" href="/z/d/graphic/60693.html" rel="external">figure 3</a>) and hydrogen ions from the intercalated cells into the tubular lumen  (<a class="graphic graphic_figure graphicRef51361" href="/z/d/graphic/51361.html" rel="external">figure 4</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Thus, any defect or physiologic alteration that impairs or reduces sodium reabsorption in the connecting segment and cortical collecting tubule will tend to produce <strong>both metabolic acidosis and</strong> <strong>hyperkalemia</strong> [<a href="#rid66">66,67</a>].</p><p></p><p>The principal causes of hyperchloremic, hyperkalemic acidosis due to impaired distal tubule sodium reabsorption include the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Voltage-dependent renal tubular acidosis (RTA):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Markedly reduced distal sodium delivery as a result of either reduced sodium intake and/or increased proximal tubule sodium reabsorption</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>An inherited or acquired defect in the sodium transport mechanisms in the principal cells</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hypoaldosteronism:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Aldosterone is the most important hormone regulating distal tubule sodium reabsorption. Hypoaldosteronism can be due either to inadequate synthesis of the hormone or resistance to its effect in the kidney.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Diminished aldosterone synthesis may be due to an acquired or inherited defect in adrenal synthesis or to reduced renin and/or angiotensin II levels.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Resistance to the action of aldosterone, which can result from structural or molecular defects in principal cells or drugs that antagonize aldosterone or inhibit its effect via other mechanisms.</p><p></p><p>The hyperkalemia in these forms of RTA is a major contributor to the development of metabolic acidosis. Hyperkalemia inhibits ammoniagenesis and reduces urine ammonium excretion. The mechanisms responsible for this inhibition are discussed in detail elsewhere (see  <a class="medical medical_review" href="/z/d/html/2306.html" rel="external">"Etiology, diagnosis, and treatment of hypoaldosteronism (type 4 RTA)", section on 'Metabolic acidosis'</a> and  <a class="medical medical_review" href="/z/d/html/2353.html" rel="external">"Potassium balance in acid-base disorders", section on 'Metabolic acidosis'</a>). In many patients with hyperkalemic forms of RTA, correction of the hyperkalemia reduces the severity of the metabolic acidosis or, if there are no other contributing factors (such as chronic kidney disease), completely reverses the metabolic acidosis [<a href="#rid68">68,69</a>].</p><p class="headingAnchor" id="H2257490"><span class="h2">Voltage-dependent RTA</span><span class="headingEndMark"> — </span>Voltage-dependent (also called "voltage-defect") renal tubular acidoses (RTAs) can occur with markedly reduced distal sodium delivery or with inherited or acquired defects in sodium reabsorption by the principal cells [<a href="#rid70">70</a>]. Sometimes, these disorders are classified as a subtype of distal RTA. However, most experts place both voltage-dependent RTA and hypoaldosteronism in the category of "hyperkalemic RTA" [<a href="#rid70">70-72</a>].</p><p>Voltage-dependent distal RTA has been described in a number of clinical settings; many of these disorders can also generate other distal tubule acidification pathology including classic distal RTA and various forms of hypoaldosteronism.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Severe hypovolemia</strong> – Some patients with severe volume contraction due, for example, to long-term laxative abuse may develop a pure voltage-dependent RTA [<a href="#rid73">73</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Urinary tract obstruction</strong> – Urinary tract obstruction can injure tubule cells and reduce the activity of the cellular Na-K-ATPase pump [<a href="#rid74">74</a>]. This may diminish sodium reabsorption [<a href="#rid75">75</a>]. However, urinary obstruction can also generate a wide spectrum of other acidification disorders including hypoaldosteronism (related to hyporeninemia), tubule resistance to aldosterone, and other forms of distal tubule voltage defects [<a href="#rid74">74</a>]. (See  <a class="medical medical_review" href="/z/d/html/7174.html" rel="external">"Clinical manifestations and diagnosis of urinary tract obstruction (UTO) and hydronephrosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lupus nephritis</strong> – Lupus nephritis can be associated with voltage-dependent RTA, although intercalated cell H-ATPase activity usually appears to be intact  (<a class="graphic graphic_figure graphicRef51361" href="/z/d/graphic/51361.html" rel="external">figure 4</a>) [<a href="#rid71">71,76</a>]. (See  <a class="medical medical_review" href="/z/d/html/3056.html" rel="external">"Lupus nephritis: Diagnosis and classification"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sickle cell disease</strong> – Sickle cell disease can produce both voltage-dependent RTA and hypoaldosteronism [<a href="#rid77">77</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Drugs </strong>– Drugs including <a class="drug drug_general" data-topicid="8550" href="/z/d/drug information/8550.html" rel="external">amiloride</a> and <a class="drug drug_general" data-topicid="9566" href="/z/d/drug information/9566.html" rel="external">lithium</a> salts, which produce voltage defects in a number of experimental models, may also have other effects on renal tubule acidification [<a href="#rid66">66</a>].</p><p></p><p class="headingAnchor" id="H348266732"><span class="h2">Hypoaldosteronism</span><span class="headingEndMark"> — </span>Aldosterone deficiency or resistance produces a hyperkalemic RTA that is often called "type 4 RTA." Compared with voltage-dependent RTA, the hyperkalemia and metabolic acidosis associated with hypoaldosteronism is milder. The serum bicarbonate is usually greater than 15 mEq/L [<a href="#rid78">78</a>], and the urine pH can usually be reduced below 5.5 [<a href="#rid79">79</a>].</p><p>The acidification defect in most patients with aldosterone deficiency or resistance is thought to be primarily due to a reduced <strong>rate</strong> of proton secretion rather than an intrinsic defect in the tubule's capacity to generate a normal pH gradient [<a href="#rid80">80,81</a>]. Thus, when very little buffer (ammonia and/or phosphate) is present in the renal tubule lumen, the pH can be reduced below pH 5.5 (but the quantity of excreted acid is relatively low). By contrast, when greater amounts of buffer are present in the distal tubule, the impaired rate of hydrogen ion secretion is unable to normally protonate the buffer load and the urine pH increases above 5.5. In either case, the reduction in net acid excretion results in metabolic acidosis.</p><p>Hyperkalemia itself will reduce renal ammonia generation and excretion. This may be related to relative alkalization of renal tubule cells (hyperkalemia will shift potassium ions into cells in exchange for hydrogen ions). The metabolic acidosis in many such patients will improve, or resolve entirely, when serum potassium levels are reduced (ie, with potassium-binding medications).</p><p>These disorders, including rare forms of aldosterone resistance such as pseudohypoaldosteronism type 2, or Gordon's syndrome, are presented elsewhere in detail. (See  <a class="medical medical_review" href="/z/d/html/2306.html" rel="external">"Etiology, diagnosis, and treatment of hypoaldosteronism (type 4 RTA)"</a>.)</p><p class="headingAnchor" id="H2258787"><span class="h2">Distinguishing voltage-dependent RTA from hypoaldosteronism</span><span class="headingEndMark"> — </span>If a patient has hyperchloremic (normal anion gap) metabolic acidosis and hyperkalemia, and both the measured serum aldosterone and renin levels are reduced, then a diagnosis of hyporeninemic hypoaldosteronism can be established. This is probably the commonest form of hyperkalemic RTA. If the aldosterone level is reduced but the renin level is elevated, then an adrenal aldosterone synthetic defect may exist. However, if the aldosterone level is elevated, it is difficult to distinguish between aldosterone resistance and a voltage-dependent form of RTA. Sometimes, multiple pathologies coexist [<a href="#rid70">70</a>], and H-ATPase defects have also been identified in some patients with hyperkalemic forms of RTA [<a href="#rid82">82</a>].</p><p>However, while the various forms of hyperkalemic RTA have a variety of underlying pathophysiologic etiologies that may be difficult to distinguish from one another, from the practical clinical and therapeutic perspective, it is usually not important to differentiate these disorders. Most patients will improve with correction of the patient's volume status and hyperkalemia.</p><p class="headingAnchor" id="H861245172"><span class="h1">TYPE 3 RTA</span><span class="headingEndMark"> — </span>The term type 3 renal tubular acidosis (RTA) is not a well-defined diagnosis and is rarely used. When it is used, this term refers to patients with both proximal and distal acidification defects. Thus, patients with genetic or drug-related carbonic anhydrase disorders could be classified as a form of "type 3 RTA."</p><p class="headingAnchor" id="H5491027"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Classification of renal tubular acidosis</strong> – There are three major forms of RTA: distal (type 1), proximal (type 2), and hyperkalemic. Hyperkalemic RTAs include hypoaldosteronism (type 4) and voltage-dependent RTA, which is sometimes considered a subtype of distal RTA. These major forms of RTA differ in their pathophysiology and clinical manifestations  (<a class="graphic graphic_table graphicRef58428" href="/z/d/graphic/58428.html" rel="external">table 1</a>) (see <a class="local">'Potassium metabolism by the kidney'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Distal (type 1) RTA is characterized by impaired hydrogen ion secretion in the distal nephron resulting either from decreased net activity of the proton pump (see <a class="local">'Decreased net activity of proton pumps and HCO3 exchangers'</a> above) or from increased luminal membrane hydrogen ion permeability (see <a class="local">'Increased luminal membrane permeability'</a> above). The plasma bicarbonate concentration can fall below 10 mEq/L in the absence of treatment with exogenous alkali. Patients with distal RTA almost always have hypocitraturia and frequently develop kidney calcifications and calcium-containing kidney stones. (See <a class="local">'Distal (type 1) RTA'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Proximal RTA is caused by proximal tubule defects that reduce the capacity to reclaim filtered bicarbonate  (<a class="graphic graphic_table graphicRef68165" href="/z/d/graphic/68165.html" rel="external">table 3</a>). Proximal RTA is often associated with Fanconi syndrome, which is characterized by defective reabsorption of other substances that are normally reabsorbed in the proximal tubule, such as phosphate, uric acid, glucose, and amino acids. (See <a class="local">'Proximal (type 2) RTA'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hypoaldosteronism is caused by reductions in aldosterone secretion or responsiveness  (<a class="graphic graphic_table graphicRef82440" href="/z/d/graphic/82440.html" rel="external">table 4</a>). (See <a class="local">'Hyperkalemic forms of RTA'</a> above and <a class="local">'Hypoaldosteronism'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Voltage-dependent RTA is caused by defects in distal sodium reabsorption. (See <a class="local">'Hyperkalemic forms of RTA'</a> above and <a class="local">'Voltage-dependent RTA'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Effect of RTA on potassium balance</strong> – Potassium balance is frequently abnormal in patients with RTA:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hypokalemia, due to renal potassium wasting, frequently develops in patients with distal RTA and usually improves with alkali therapy. (See <a class="local">'Distal (type 1) RTA'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hypokalemia may also develop in patients with proximal RTA. However, in contrast to distal RTA, alkali therapy usually generates or exacerbates hypokalemia in patients with proximal RTA. (See <a class="local">'Proximal (type 2) RTA'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hyperkalemia occurs frequently in patients with hypoaldosteronism (type 4 RTA) and in patients with other defects in sodium reabsorption in their distal nephron (voltage-dependent RTA). (See <a class="local">'Hyperkalemic forms of RTA'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Rodríguez Soriano J. Renal tubular acidosis: the clinical entity. J Am Soc Nephrol 2002; 13:2160.</a></li><li><a class="nounderline abstract_t">Gluck SL. Acid-base. Lancet 1998; 352:474.</a></li><li><a class="nounderline abstract_t">Harris AN, Skankar M, Melanmed M, Batlle D. An Update on Kidney Ammonium Transport Along the Nephron. Adv Kidney Dis Health 2023; 30:189.</a></li><li><a class="nounderline abstract_t">Unwin RJ, Luft FC, Shirley DG. Pathophysiology and management of hypokalemia: a clinical perspective. Nat Rev Nephrol 2011; 7:75.</a></li><li class="breakAll">Rose BD, Post TW. Clinical Physiology of Acid-Base and Electrolyte Disorders, 5th ed, McGraw-Hill, New York 2001. p.357.</li><li><a class="nounderline abstract_t">Stanton BA. Renal potassium transport: morphological and functional adaptations. Am J Physiol 1989; 257:R989.</a></li><li><a class="nounderline abstract_t">Young DB. Quantitative analysis of aldosterone's role in potassium regulation. Am J Physiol 1988; 255:F811.</a></li><li><a class="nounderline abstract_t">Hoorn EJ, Nelson JH, McCormick JA, Ellison DH. The WNK kinase network regulating sodium, potassium, and blood pressure. J Am Soc Nephrol 2011; 22:605.</a></li><li class="breakAll">Rose BD, Post TW. Clinical Physiology of Acid-Base and Electrolyte Disorders, 5th ed, McGraw-Hill, New York 2001. p.616.</li><li><a class="nounderline abstract_t">Sebastian A, McSherry E, Morris RC Jr. Renal potassium wasting in renal tubular acidosis (RTA): its occurrence in types 1 and 2 RTA despite sustained correction of systemic acidosis. J Clin Invest 1971; 50:667.</a></li><li><a class="nounderline abstract_t">Poux JM, Peyronnet P, Le Meur Y, et al. Hypokalemic quadriplegia and respiratory arrest revealing primary Sjögren's syndrome. Clin Nephrol 1992; 37:189.</a></li><li><a class="nounderline abstract_t">Giebisch G, Wang W. Potassium transport: from clearance to channels and pumps. Kidney Int 1996; 49:1624.</a></li><li><a class="nounderline abstract_t">Giebisch G. Challenges to potassium metabolism: internal distribution and external balance. Wien Klin Wochenschr 2004; 116:353.</a></li><li><a class="nounderline abstract_t">Wagner CA, Unwin R, Lopez-Garcia SC, et al. The pathophysiology of distal renal tubular acidosis. Nat Rev Nephrol 2023; 19:384.</a></li><li><a class="nounderline abstract_t">Kim S, Lee JW, Park J, et al. The urine-blood PCO gradient as a diagnostic index of H(+)-ATPase defect distal renal tubular acidosis. Kidney Int 2004; 66:761.</a></li><li><a class="nounderline abstract_t">Strife CF, Clardy CW, Varade WS, et al. Urine-to-blood carbon dioxide tension gradient and maximal depression of urinary pH to distinguish rate-dependent from classic distal renal tubular acidosis in children. J Pediatr 1993; 122:60.</a></li><li><a class="nounderline abstract_t">Han JS, Kim GH, Kim J, et al. Secretory-defect distal renal tubular acidosis is associated with transporter defect in H(+)-ATPase and anion exchanger-1. J Am Soc Nephrol 2002; 13:1425.</a></li><li><a class="nounderline abstract_t">Cohen EP, Bastani B, Cohen MR, et al. Absence of H(+)-ATPase in cortical collecting tubules of a patient with Sjogren's syndrome and distal renal tubular acidosis. J Am Soc Nephrol 1992; 3:264.</a></li><li><a class="nounderline abstract_t">Bastani B, Haragsim L, Gluck S, Siamopoulos KC. Lack of H-ATPase in distal nephron causing hypokalaemic distal RTA in a patient with Sjögren's syndrome. Nephrol Dial Transplant 1995; 10:908.</a></li><li><a class="nounderline abstract_t">Takemoto F, Hoshino J, Sawa N, et al. Autoantibodies against carbonic anhydrase II are increased in renal tubular acidosis associated with Sjogren syndrome. Am J Med 2005; 118:181.</a></li><li><a class="nounderline abstract_t">Walsh S, Borgese F, Gabillat N, et al. Cation transport activity of anion exchanger 1 mutations found in inherited distal renal tubular acidosis. Am J Physiol Renal Physiol 2008; 295:F343.</a></li><li><a class="nounderline abstract_t">Bruce LJ, Cope DL, Jones GK, et al. Familial distal renal tubular acidosis is associated with mutations in the red cell anion exchanger (Band 3, AE1) gene. J Clin Invest 1997; 100:1693.</a></li><li><a class="nounderline abstract_t">Jarolim P, Shayakul C, Prabakaran D, et al. Autosomal dominant distal renal tubular acidosis is associated in three families with heterozygosity for the R589H mutation in the AE1 (band 3) Cl-/HCO3- exchanger. J Biol Chem 1998; 273:6380.</a></li><li><a class="nounderline abstract_t">Karet FE, Gainza FJ, Györy AZ, et al. Mutations in the chloride-bicarbonate exchanger gene AE1 cause autosomal dominant but not autosomal recessive distal renal tubular acidosis. Proc Natl Acad Sci U S A 1998; 95:6337.</a></li><li><a class="nounderline abstract_t">Wrong O, Bruce LJ, Unwin RJ, et al. Band 3 mutations, distal renal tubular acidosis, and Southeast Asian ovalocytosis. Kidney Int 2002; 62:10.</a></li><li><a class="nounderline abstract_t">Karet FE. Inherited distal renal tubular acidosis. J Am Soc Nephrol 2002; 13:2178.</a></li><li><a class="nounderline abstract_t">Yenchitsomanus PT, Vasuvattakul S, Kirdpon S, et al. Autosomal recessive distal renal tubular acidosis caused by G701D mutation of anion exchanger 1 gene. Am J Kidney Dis 2002; 40:21.</a></li><li><a class="nounderline abstract_t">Devonald MA, Smith AN, Poon JP, et al. Non-polarized targeting of AE1 causes autosomal dominant distal renal tubular acidosis. Nat Genet 2003; 33:125.</a></li><li><a class="nounderline abstract_t">Sritippayawan S, Sumboonnanonda A, Vasuvattakul S, et al. Novel compound heterozygous SLC4A1 mutations in Thai patients with autosomal recessive distal renal tubular acidosis. Am J Kidney Dis 2004; 44:64.</a></li><li><a class="nounderline abstract_t">Nicoletta JA, Schwartz GJ. Distal renal tubular acidosis. Curr Opin Pediatr 2004; 16:194.</a></li><li><a class="nounderline abstract_t">Fry AC, Su Y, Yiu V, et al. Mutation conferring apical-targeting motif on AE1 exchanger causes autosomal dominant distal RTA. J Am Soc Nephrol 2012; 23:1238.</a></li><li><a class="nounderline abstract_t">Toye AM. Defective kidney anion-exchanger 1 (AE1, Band 3) trafficking in dominant distal renal tubular acidosis (dRTA). Biochem Soc Symp 2005; :47.</a></li><li><a class="nounderline abstract_t">Rungroj N, Devonald MA, Cuthbert AW, et al. A novel missense mutation in AE1 causing autosomal dominant distal renal tubular acidosis retains normal transport function but is mistargeted in polarized epithelial cells. J Biol Chem 2004; 279:13833.</a></li><li><a class="nounderline abstract_t">Shayakul C, Alper SL. Defects in processing and trafficking of the AE1 Cl-/HCO3- exchanger associated with inherited distal renal tubular acidosis. Clin Exp Nephrol 2004; 8:1.</a></li><li><a class="nounderline abstract_t">Ribeiro ML, Alloisio N, Almeida H, et al. Severe hereditary spherocytosis and distal renal tubular acidosis associated with the total absence of band 3. Blood 2000; 96:1602.</a></li><li><a class="nounderline abstract_t">Toye AM, Williamson RC, Khanfar M, et al. Band 3 Courcouronnes (Ser667Phe): a trafficking mutant differentially rescued by wild-type band 3 and glycophorin A. Blood 2008; 111:5380.</a></li><li><a class="nounderline abstract_t">Walsh S, Borgese F, Gabillat N, Guizouarn H. Southeast Asian AE1 associated renal tubular acidosis: cation leak is a class effect. Biochem Biophys Res Commun 2009; 382:668.</a></li><li><a class="nounderline abstract_t">Karet FE, Finberg KE, Nelson RD, et al. Mutations in the gene encoding B1 subunit of H+-ATPase cause renal tubular acidosis with sensorineural deafness. Nat Genet 1999; 21:84.</a></li><li><a class="nounderline abstract_t">Vargas-Poussou R, Houillier P, Le Pottier N, et al. Genetic investigation of autosomal recessive distal renal tubular acidosis: evidence for early sensorineural hearing loss associated with mutations in the ATP6V0A4 gene. J Am Soc Nephrol 2006; 17:1437.</a></li><li><a class="nounderline abstract_t">Gueutin V, Vallet M, Jayat M, et al. Renal β-intercalated cells maintain body fluid and electrolyte balance. J Clin Invest 2013; 123:4219.</a></li><li><a class="nounderline abstract_t">Wang T, Egbert AL Jr, Aronson PS, Giebisch G. Effect of metabolic acidosis on NaCl transport in the proximal tubule. Am J Physiol 1998; 274:F1015.</a></li><li><a class="nounderline abstract_t">Wingo CS, Smolka AJ. Function and structure of H-K-ATPase in the kidney. Am J Physiol 1995; 269:F1.</a></li><li><a class="nounderline abstract_t">Silver RB, Soleimani M. H+-K+-ATPases: regulation and role in pathophysiological states. Am J Physiol 1999; 276:F799.</a></li><li><a class="nounderline abstract_t">Dafnis E, Spohn M, Lonis B, et al. Vanadate causes hypokalemic distal renal tubular acidosis. Am J Physiol 1992; 262:F449.</a></li><li><a class="nounderline abstract_t">Douglas JB, Healy JK. Nephrotoxic effects of amphotericin B, including renal tubular acidosis. Am J Med 1969; 46:154.</a></li><li><a class="nounderline abstract_t">Atsmon J, Dolev E. Drug-induced hypomagnesaemia : scope and management. Drug Saf 2005; 28:763.</a></li><li><a class="nounderline abstract_t">Wazny LD, Brophy DF. Amiloride for the prevention of amphotericin B-induced hypokalemia and hypomagnesemia. Ann Pharmacother 2000; 34:94.</a></li><li><a class="nounderline abstract_t">Buckalew VM Jr, McCurdy DK, Ludwig GD, et al. Incomplete renal tubular acidosis. Physiologic studies in three patients with a defect in lowering urine pH. Am J Med 1968; 45:32.</a></li><li><a class="nounderline abstract_t">Zhang J, Fuster DG, Cameron MA, et al. Incomplete distal renal tubular acidosis from a heterozygous mutation of the V-ATPase B1 subunit. Am J Physiol Renal Physiol 2014; 307:F1063.</a></li><li><a class="nounderline abstract_t">Donnelly S, Kamel KS, Vasuvattakul S, et al. Might distal renal tubular acidosis be a proximal tubular cell disorder? Am J Kidney Dis 1992; 19:272.</a></li><li><a class="nounderline abstract_t">Hamm LL. Renal handling of citrate. Kidney Int 1990; 38:728.</a></li><li><a class="nounderline abstract_t">Morris RC Jr, Sebastian A. Alkali therapy in renal tubular acidosis: who needs it? J Am Soc Nephrol 2002; 13:2186.</a></li><li><a class="nounderline abstract_t">Pongchaiyakul C, Domrongkitchaiporn S, Stitchantrakul W, et al. Incomplete renal tubular acidosis and bone mineral density: a population survey in an area of endemic renal tubular acidosis. Nephrol Dial Transplant 2004; 19:3029.</a></li><li><a class="nounderline abstract_t">Igarashi T, Sekine T, Inatomi J, Seki G. Unraveling the molecular pathogenesis of isolated proximal renal tubular acidosis. J Am Soc Nephrol 2002; 13:2171.</a></li><li><a class="nounderline abstract_t">Igarashi T, Inatomi J, Sekine T, et al. Mutations in SLC4A4 cause permanent isolated proximal renal tubular acidosis with ocular abnormalities. Nat Genet 1999; 23:264.</a></li><li><a class="nounderline abstract_t">Sly WS, Whyte MP, Sundaram V, et al. Carbonic anhydrase II deficiency in 12 families with the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. N Engl J Med 1985; 313:139.</a></li><li><a class="nounderline abstract_t">Shah GN, Bonapace G, Hu PY, et al. Carbonic anhydrase II deficiency syndrome (osteopetrosis with renal tubular acidosis and brain calcification): novel mutations in CA2 identified by direct sequencing expand the opportunity for genotype-phenotype correlation. Hum Mutat 2004; 24:272.</a></li><li><a class="nounderline abstract_t">Sonia HL, Mohamed F, Mohamed B, et al. [Osteopetrosis with carbonic anhydrase II deficiency: report of 24 cases]. Tunis Med 2005; 83:409.</a></li><li><a class="nounderline abstract_t">Sirac C, Bridoux F, Essig M, et al. Toward understanding renal Fanconi syndrome: step by step advances through experimental models. Contrib Nephrol 2011; 169:247.</a></li><li><a class="nounderline abstract_t">Haque SK, Ariceta G, Batlle D. Proximal renal tubular acidosis: a not so rare disorder of multiple etiologies. Nephrol Dial Transplant 2012; 27:4273.</a></li><li><a class="nounderline abstract_t">Lacy MQ, Gertz MA. Acquired Fanconi's syndrome associated with monoclonal gammopathies. Hematol Oncol Clin North Am 1999; 13:1273.</a></li><li><a class="nounderline abstract_t">McSherry E. Renal tubular acidosis in childhood. Kidney Int 1981; 20:799.</a></li><li><a class="nounderline abstract_t">Manz F, Waldherr R, Fritz HP, et al. Idiopathic de Toni-Debré-Fanconi syndrome with absence of proximal tubular brush border. Clin Nephrol 1984; 22:149.</a></li><li><a class="nounderline abstract_t">Cogan MG, Rector FC Jr. Proximal reabsorption during metabolic acidosis in the rat. Am J Physiol 1982; 242:F499.</a></li><li><a class="nounderline abstract_t">Sebastian A, McSherry E, Morris RC Jr. On the mechanism of renal potassium wasting in renal tubular acidosis associated with the Fanconi syndrome (type 2 RTA). J Clin Invest 1971; 50:231.</a></li><li><a class="nounderline abstract_t">Kurtzman NA. Disorders of distal acidification. Kidney Int 1990; 38:720.</a></li><li><a class="nounderline abstract_t">Batlle DC. Segmental characterization of defects in collecting tubule acidification. Kidney Int 1986; 30:546.</a></li><li><a class="nounderline abstract_t">Szylman P, Better OS, Chaimowitz C, Rosler A. Role of hyperkalemia in the metabolic acidosis of isolated hypoaldosteronism. N Engl J Med 1976; 294:361.</a></li><li><a class="nounderline abstract_t">Matsuda O, Nonoguchi H, Tomita K, et al. Primary role of hyperkalemia in the acidosis of hyporeninemic hypoaldosteronism. Nephron 1988; 49:203.</a></li><li><a class="nounderline abstract_t">Kurtzman NA. Renal tubular acidosis syndromes. South Med J 2000; 93:1042.</a></li><li><a class="nounderline abstract_t">Li SL, Liou LB, Fang JT, Tsai WP. Symptomatic renal tubular acidosis (RTA) in patients with systemic lupus erythematosus: an analysis of six cases with new association of type 4 RTA. Rheumatology (Oxford) 2005; 44:1176.</a></li><li><a class="nounderline abstract_t">Karet FE. Mechanisms in hyperkalemic renal tubular acidosis. J Am Soc Nephrol 2009; 20:251.</a></li><li><a class="nounderline abstract_t">Batlle DC, von Riotte A, Schlueter W. Urinary sodium in the evaluation of hyperchloremic metabolic acidosis. N Engl J Med 1987; 316:140.</a></li><li><a class="nounderline abstract_t">Batlle DC, Arruda JA, Kurtzman NA. Hyperkalemic distal renal tubular acidosis associated with obstructive uropathy. N Engl J Med 1981; 304:373.</a></li><li><a class="nounderline abstract_t">Sabatini S, Kurtzman NA. Enzyme activity in obstructive uropathy: basis for salt wastage and the acidification defect. Kidney Int 1990; 37:79.</a></li><li><a class="nounderline abstract_t">Bastani B, Underhill D, Chu N, et al. Preservation of intercalated cell H(+)-ATPase in two patients with lupus nephritis and hyperkalemic distal renal tubular acidosis. J Am Soc Nephrol 1997; 8:1109.</a></li><li><a class="nounderline abstract_t">Batlle D, Itsarayoungyuen K, Arruda JA, Kurtzman NA. Hyperkalemic hyperchloremic metabolic acidosis in sickle cell hemoglobinopathies. Am J Med 1982; 72:188.</a></li><li><a class="nounderline abstract_t">Batlle DC, Hizon M, Cohen E, et al. The use of the urinary anion gap in the diagnosis of hyperchloremic metabolic acidosis. N Engl J Med 1988; 318:594.</a></li><li><a class="nounderline abstract_t">Sebastian A, Hulter HN, Kurtz I, et al. Disorders of distal nephron function. Am J Med 1982; 72:289.</a></li><li><a class="nounderline abstract_t">Hulter HN, Ilnicki LP, Harbottle JA, Sebastian A. Impaired renal H+ secretion and NH3 production in mineralocorticoid-deficient glucocorticoid-replete dogs. Am J Physiol 1977; 232:F136.</a></li><li><a class="nounderline abstract_t">Hulter HN, Licht JH, Glynn RD, et al. Pathophysiology of chronic renal tubular acidosis induced by administration of amiloride. J Lab Clin Med 1980; 95:637.</a></li><li><a class="nounderline abstract_t">Schlueter W, Keilani T, Hizon M, et al. On the mechanism of impaired distal acidification in hyperkalemic renal tubular acidosis: evaluation with amiloride and bumetanide. J Am Soc Nephrol 1992; 3:953.</a></li></ol></div><div id="topicVersionRevision">Topic 2327 Version 23.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12138150" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Renal tubular acidosis: the clinical entity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9708770" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Acid-base.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36868733" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : An Update on Kidney Ammonium Transport Along the Nephron.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21278718" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Pathophysiology and management of hypokalemia: a clinical perspective.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21278718" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Pathophysiology and management of hypokalemia: a clinical perspective.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2686470" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Renal potassium transport: morphological and functional adaptations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3056039" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Quantitative analysis of aldosterone's role in potassium regulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21436285" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : The WNK kinase network regulating sodium, potassium, and blood pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21436285" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : The WNK kinase network regulating sodium, potassium, and blood pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5101785" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Renal potassium wasting in renal tubular acidosis (RTA): its occurrence in types 1 and 2 RTA despite sustained correction of systemic acidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1582057" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Hypokalemic quadriplegia and respiratory arrest revealing primary Sjögren's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8743466" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Potassium transport: from clearance to channels and pumps.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15291287" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Challenges to potassium metabolism: internal distribution and external balance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37016093" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : The pathophysiology of distal renal tubular acidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15253731" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : The urine-blood PCO gradient as a diagnostic index of H(+)-ATPase defect distal renal tubular acidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8419615" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Urine-to-blood carbon dioxide tension gradient and maximal depression of urinary pH to distinguish rate-dependent from classic distal renal tubular acidosis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12039970" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Secretory-defect distal renal tubular acidosis is associated with transporter defect in H(+)-ATPase and anion exchanger-1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1391725" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Absence of H(+)-ATPase in cortical collecting tubules of a patient with Sjogren's syndrome and distal renal tubular acidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7566631" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Lack of H-ATPase in distal nephron causing hypokalaemic distal RTA in a patient with Sjögren's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15694905" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Autoantibodies against carbonic anhydrase II are increased in renal tubular acidosis associated with Sjogren syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18524859" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Cation transport activity of anion exchanger 1 mutations found in inherited distal renal tubular acidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9312167" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Familial distal renal tubular acidosis is associated with mutations in the red cell anion exchanger (Band 3, AE1) gene.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9497368" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Autosomal dominant distal renal tubular acidosis is associated in three families with heterozygosity for the R589H mutation in the AE1 (band 3) Cl-/HCO3- exchanger.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9600966" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Mutations in the chloride-bicarbonate exchanger gene AE1 cause autosomal dominant but not autosomal recessive distal renal tubular acidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12081559" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Band 3 mutations, distal renal tubular acidosis, and Southeast Asian ovalocytosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12138152" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Inherited distal renal tubular acidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12087557" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Autosomal recessive distal renal tubular acidosis caused by G701D mutation of anion exchanger 1 gene.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12539048" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Non-polarized targeting of AE1 causes autosomal dominant distal renal tubular acidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15211439" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Novel compound heterozygous SLC4A1 mutations in Thai patients with autosomal recessive distal renal tubular acidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15021201" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Distal renal tubular acidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22518001" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Mutation conferring apical-targeting motif on AE1 exchanger causes autosomal dominant distal RTA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15649129" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Defective kidney anion-exchanger 1 (AE1, Band 3) trafficking in dominant distal renal tubular acidosis (dRTA).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14734552" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : A novel missense mutation in AE1 causing autosomal dominant distal renal tubular acidosis retains normal transport function but is mistargeted in polarized epithelial cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15067510" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Defects in processing and trafficking of the AE1 Cl-/HCO3- exchanger associated with inherited distal renal tubular acidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10942416" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Severe hereditary spherocytosis and distal renal tubular acidosis associated with the total absence of band 3.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18174378" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Band 3 Courcouronnes (Ser667Phe): a trafficking mutant differentially rescued by wild-type band 3 and glycophorin A.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19289107" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Southeast Asian AE1 associated renal tubular acidosis: cation leak is a class effect.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9916796" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Mutations in the gene encoding B1 subunit of H+-ATPase cause renal tubular acidosis with sensorineural deafness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16611712" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Genetic investigation of autosomal recessive distal renal tubular acidosis: evidence for early sensorineural hearing loss associated with mutations in the ATP6V0A4 gene.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24051376" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Renalβ-intercalated cells maintain body fluid and electrolyte balance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9841491" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Effect of metabolic acidosis on NaCl transport in the proximal tubule.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7631822" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Function and structure of H-K-ATPase in the kidney.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10362769" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : H+-K+-ATPases: regulation and role in pathophysiological states.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1313645" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Vanadate causes hypokalemic distal renal tubular acidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4951424" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Nephrotoxic effects of amphotericin B, including renal tubular acidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16119971" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Drug-induced hypomagnesaemia : scope and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10669191" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Amiloride for the prevention of amphotericin B-induced hypokalemia and hypomagnesemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5658867" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Incomplete renal tubular acidosis. Physiologic studies in three patients with a defect in lowering urine pH.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25164082" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Incomplete distal renal tubular acidosis from a heterozygous mutation of the V-ATPase B1 subunit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1553972" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Might distal renal tubular acidosis be a proximal tubular cell disorder?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2232510" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Renal handling of citrate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12138154" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Alkali therapy in renal tubular acidosis: who needs it?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15479744" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Incomplete renal tubular acidosis and bone mineral density: a population survey in an area of endemic renal tubular acidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12138151" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Unraveling the molecular pathogenesis of isolated proximal renal tubular acidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10545938" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Mutations in SLC4A4 cause permanent isolated proximal renal tubular acidosis with ocular abnormalities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3925334" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Carbonic anhydrase II deficiency in 12 families with the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15300855" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Carbonic anhydrase II deficiency syndrome (osteopetrosis with renal tubular acidosis and brain calcification): novel mutations in CA2 identified by direct sequencing expand the opportunity for genotype-phenotype correlation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16220698" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : [Osteopetrosis with carbonic anhydrase II deficiency: report of 24 cases].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21252524" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Toward understanding renal Fanconi syndrome: step by step advances through experimental models.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23235953" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Proximal renal tubular acidosis: a not so rare disorder of multiple etiologies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10626150" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Acquired Fanconi's syndrome associated with monoclonal gammopathies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7038264" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Renal tubular acidosis in childhood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6488596" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Idiopathic de Toni-Debré-Fanconi syndrome with absence of proximal tubular brush border.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6805335" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Proximal reabsorption during metabolic acidosis in the rat.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5101297" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : On the mechanism of renal potassium wasting in renal tubular acidosis associated with the Fanconi syndrome (type 2 RTA).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2232509" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Disorders of distal acidification.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3784293" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Segmental characterization of defects in collecting tubule acidification.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1674" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Role of hyperkalemia in the metabolic acidosis of isolated hypoaldosteronism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3398981" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Primary role of hyperkalemia in the acidosis of hyporeninemic hypoaldosteronism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11095551" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Renal tubular acidosis syndromes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15956092" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Symptomatic renal tubular acidosis (RTA) in patients with systemic lupus erythematosus: an analysis of six cases with new association of type 4 RTA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19193780" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Mechanisms in hyperkalemic renal tubular acidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3796685" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Urinary sodium in the evaluation of hyperchloremic metabolic acidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7453754" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Hyperkalemic distal renal tubular acidosis associated with obstructive uropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2153850" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Enzyme activity in obstructive uropathy: basis for salt wastage and the acidification defect.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9219160" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Preservation of intercalated cell H(+)-ATPase in two patients with lupus nephritis and hyperkalemic distal renal tubular acidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7036725" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Hyperkalemic hyperchloremic metabolic acidosis in sickle cell hemoglobinopathies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3344005" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : The use of the urinary anion gap in the diagnosis of hyperchloremic metabolic acidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6277192" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Disorders of distal nephron function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14506" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Impaired renal H+ secretion and NH3 production in mineralocorticoid-deficient glucocorticoid-replete dogs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7365313" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Pathophysiology of chronic renal tubular acidosis induced by administration of amiloride.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1450372" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : On the mechanism of impaired distal acidification in hyperkalemic renal tubular acidosis: evaluation with amiloride and bumetanide.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
